Abstracts

824 – Change in Cardiometabolic Risk Markers Following Switch to Integrase Inhibitors Differs by Sex

Background Integrase strand-transfer inhibitor (INSTI)-associated weight gain among people with HIV (PWH) is greater in women than men.  We assessed sex differences in cardiometabolic markers up to 5 years following INSTI initiation.  Methods We used data collected between 2007-2020 in INSTI-naïve PWH on antiretroviral therapy (ART) for ≥2 years with viral suppression (<200 c/mL) and…

895 – Serum Metabolomic Signatures Associated With InSTI-Related Weight Gain in Women With HIV

Background Initiation of integrase strand-transfer inhibitors (INSTIs) is associated with body weight gain in women with HIV (WWH); however underlying mechanisms are unclear. Leveraging samples from the Women’s Interagency HIV Study (WIHS) cohort, we performed serial high-throughput untargeted metabolomics to determine metabolic signatures associated with INSTI-related weight gain. Methods This study included virologically suppressed (<200…

883 – 10-Minute Targeted Geriatric Assessment Identifies Vulnerable and Frail Older Persons With HIV

Background Geriatric assessments are becoming increasingly important in HIV clinical practice as the population of older persons with HIV (PWH) expands. However, traditional instruments are often complex and time-consuming. The 10-minute geriatric assessment (10-TaGA) is a rapid, comprehensive assessment developed to screen geriatric syndromes in healthcare settings. We investigated the validity of 10-TaGA among PWH…

843 – Multiomics Analysis of Gut Microbiome and Carotid Artery Atherosclerosis in Men With and Without HIV

Background Alterations in gut microbiota have been implicated in HIV infection and cardiovascular disease (CVD). However, how gut microbial alterations may lead to host inflammation and changes in metabolomics profiles affecting atherosclerosis is not fully elucidated, especially in the context of HIV. Methods We examined associations of gut microbial species and functional components measured by shotgun metagenomics with…

866 – ART Exposure and Accelerated Aging in PLHIV: Insights From Proteomic and Methylation Clocks

Background People living with HIV (PLHIV) using antiretroviral therapy (ART) are exposed to persistent low grade of inflammation, which may accelerate aging. However, the impact of various ART regimens on residual inflammation and accelerated aging remains largely unclear. This study investigates the relationship between cumulative ART exposure and age acceleration in virally suppressed PLHIV on…

881 – Prognostic Factors of Physical Function Decline in the PREPARE Study

Background The Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE) substudy of REPRIEVE found small declines in physical function, and no evidence of pitavastatin effect. However, there was substantial individual variability, with some participants experiencing considerable declines. The purpose of this pre-specified exploratory analysis was to identify participants at a greater risk…

813 – Mitochondrial Haplogroups and Left Ventricular Dysfunction in People Living With and Without HIV

Background Mitochondrial dysfunction is implicated in the development of heart failure, which is more common in people with HIV (PWH) than those without HIV (PWoH). Whether genetic variations in mitochondrial DNA (mtDNA) are related to cardiac dysfunction, specifically left ventricular diastolic dysfunction (LVDD), has not been well studied in PWH. Methods We included men from…

860 – Racial Inequity in Initiation of Semaglutide Therapy Among People With HIV in Care Across the US

Background Antiretroviral therapy has resulted in a reduction in HIV-associated wasting among people with HIV (PWH) and a concomitant rise in overweight and obesity. Semaglutide has been difficult to obtain for some populations, we therefore evaluated use of semaglutide among PWH with medical indications assessing for potential disparities based on race/ethnicity. Methods Our study is…

842 – Multiomics Profiles of SHBG Are Associated With Subclinical Atherosclerosis in Men With HIV

Background Sex hormones and HIV infection both influence cardiovascular health. However, the relationship between sex hormones and subclinical atherosclerosis is not fully understood, especially in the context of HIV. Methods Among 321 men (65% with HIV) from the MACS/WIHS Combined Cohort Study, we measured 14 serum sex hormones and sex hormone-binding globulin (SHBG), assessed carotid…